Arrowhead Pharma Cash Flow - Quarterly (NASDAQ:ARWR)

Add to My Stocks
$18.58 $0.26 (1.38%) ARWR stock closing price Sep 19, 2018 (Closing)

For analyzing any company like Arrowhead Pharma from an investment perspective, its important to check the cash flow statement. The profit-loss statement shows Arrowhead Pharma profits, the balance sheet shows Arrowhead Pharma debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Arrowhead Pharma had cash and cash equivalents of $24.84M at beginning of the quarter and $28M at quarter end of 2018 Q3. Arrowhead Pharma cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. Arrowhead Pharma had an outflow of $-44.54M from operating activities, $58.38M inflow due to financing activities, and $-10.68M outflow due to investing activities till 2018 Q3.

View and download details of Arrowhead Pharma cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Oct - Sep2018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q2
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow4.05M2.64M1.24M4.64M3.39M2.3M1.18M3.49M2.61M1.77M
Net Increase (Decrease) in Assets Liabilities-10.29M-7.8M-4.38M-1.2M1.15M8.78M19.96M5.71M-4.67M-2.04M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net5.39M3.11M1.64M7M4.36M2.71M-8.08M7.31M4.45M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.71M-0.51M-0.13M-7.91M-7.81M-6.65M-5.29M-3.86M-1.14M-0.5M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments-9.97M18.68M1.49M-40.72M-36.61M-24.84M-17.3M16.3M6.2M
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares58.59M57.08M-12.69M12.69M12.69M12.5M55.98M2.28M-
Issuance (Repayment) of Debt Securities-0.15M-0.1M-0.19M--0.09M-0.09M-0.04M-0.21M-0.16M-0.1M
Increase (Decrease) in Bank & Other Borrowings----0.19M------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.05M-0.05M--0.43M-0.41M-0.41M-0.41M-0.63M-0.63M-0.63M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year24.84M85.36M81.21M132.51M19.11M3.37M7.5M6.84M2.02M10.09M
Cash & Equivalents at Year End28M69.8M11.53M24.83M38.38M61.71M102.1M85.36M43.61M50.3M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Arrowhead Pharma stock price history provides insight into historical stock price fluctuations, and Arrowhead Pharma stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Arrowhead Pharma is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Arrowhead Pharma stock price movement.
  • Arrowhead Pharma decreased its cash from operating activities to $-44.54M till 2018 Q3. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash from investing stood at a negative value of $-10.68M for ARWR stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Arrowhead Pharma earned $58.38M from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For Arrowhead Pharma Cash Flow